An Amino Acid-based Amphoteric Liposomal Delivery System for Systemic Administration of siRNA-Reference-Cited by-同舟云学术

An Amino Acid-based Amphoteric Liposomal Delivery System for Systemic Administration of siRNA

Published:2011-06 Issue:6 Volume:19 Page:1141-1151
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Adami Roger C,Seth Shaguna,Harvie Pierrot,Johns Rachel,Fam Renata,Fosnaugh Kathy,Zhu Tianying,Farber Ken,McCutcheon Michael,Goodman Thomas T,Liu Yan,Chen Yan,Kwang Erin,Templin Michael V,Severson Greg,Brown Tod,Vaish Narendra,Chen Feng,Charmley Patrick,Polisky Barry,Houston Michael E

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference34 articles.

1. DOTAP (and other cationic lipids): chemistry, biophysics, and transfection;Simberg;Crit Rev Ther Drug Carrier Syst,2004

2. Structural basis of DOTMA for its high intravenous transfection activity in mouse;Ren;Gene Ther,2000

3. Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes;Barron;Gene Ther,1999

4. Cationic liposome-mediated delivery of siRNAs in adult mice;Sioud;Biochem Biophys Res Commun,2003

5. Barriers to successful delivery of short interfering RNA after systemic administration;White;Clin Exp Pharmacol Physiol,2008

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivery of small interfering ribonucleic acid using lipid nanoparticles prepared with pH-responsive dipeptide-conjugated lipids;Biochemical and Biophysical Research Communications;2024-10

2. Guanidinium-based Integrated Peptide Dendrimers: Pioneer Nanocarrier in Cancer Therapy;Protein & Peptide Letters;2024-04

3. Biodegradable Cationic and Ionizable Cationic Lipids: A Roadmap for Safer Pharmaceutical Excipients;Small;2023-01-06

4. RGD peptide-based lipids for targeted mRNA delivery and gene editing applications;RSC Advances;2022

5. Making Sense of Antisense Oligonucleotide Therapeutics Targeting Bcl-2;Pharmaceutics;2022-01-01